Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson's Disease: A New Therapeutic Strategy

Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson's Disease: A New Therapeutic Strategy

Pallàs M, Vázquez S, Sanfeliu C, Galdeano C, Griñán-Ferré C.,
2020
References: 
Biomolecules. 2020 May 1;10(5):703. doi: 10.3390/biom10050703.
  • Associated Personnel

    Coral Sanfeliu Pujol

    Research Scientist
  • Associated Research Groups
  • Associated Departments

    Neuroscience and Experimental Therapeutics.

    The department studies the biological bases and molecular mechanisms of brain aging and brain pathologies, including neurodegenerative, cerebrovascular, and neuroinflammatory diseases. In the same way, it addresses the study of brain circuits and synaptic processes involved in neuropsychiatric disorders such as depression and schizophrenia.

    Read more